Patents by Inventor Matthew Harriton

Matthew Harriton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8911782
    Abstract: Crosslinked hydrogel-based transdermal pharmaceutical formulations. The hydrogel transdermal formulations. Transdermal patches are useful for administering a variety of drugs to patients. The transdermal patches here employ crosslinked-hydrogels generated through irradiation, thus eliminating any residual effects associated with chemical- or UV-based crosslinking procedures. The transdermal patches may be formed from a variety of high-molecular weight polymeric compounds and include substantial levels of water to improve skin tolerance by the patient. The transdermal patches may also include transcutol as a solvent for the drug, which has been found to increase the effectiveness of drug delivery. The present disclosure also provides for methods of loading a drug into a transdermal formulation after the crosslinking of the hydrogel, thus improving stability and bioavailability through avoiding exposure of the drug to the radiation used in the crosslinking procedure.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: December 16, 2014
    Assignee: Specialty Pharmaceutical Products LLC
    Inventors: Matthew Harriton, Gregory Robb, Ronald S. Harland
  • Publication number: 20130078299
    Abstract: Crosslinked hydrogel-based transdermal pharmaceutical formulations. The hydrogel transdermal formulations. Transdermal patches are useful for administering a variety of drugs to patients. The transdermal patches here employ crosslinked-hydrogels generated through irradiation, thus eliminating any residual effects associated with chemical- or UV-based crosslinking procedures. The transdermal patches may be formed from a variety of high-molecular weight polymeric compounds and include substantial levels of water to improve skin tolerance by the patient. The transdermal patches may also include transcutol as a solvent for the drug, which has been found to increase the effectiveness of drug delivery. The present disclosure also provides for methods of loading a drug into a transdermal formulation after the crosslinking of the hydrogel, thus improving stability and bioavailability through avoiding exposure of the drug to the radiation used in the crosslinking procedure.
    Type: Application
    Filed: April 11, 2012
    Publication date: March 28, 2013
    Applicant: Alliqua, Inc.
    Inventors: Matthew HARRITON, Gregory Robb, Ronald S. Harland
  • Publication number: 20070134307
    Abstract: An antimicrobial composite is provided, comprising a catalyst capable of promoting oxidation of organic molecules incorporated in a carrier, for example a hydrophilic or water-based material, the catalyst configured such that it will not discolor surrounding material under the influence of oxidative conditions
    Type: Application
    Filed: June 26, 2006
    Publication date: June 14, 2007
    Inventors: T. Xiao, Jinxiang Dai, Junfeng Zhou, Meidong Wang, Michael Gray, Gregory Robb, Barry Constantine, David Reisner, Matthew Harriton
  • Publication number: 20060062854
    Abstract: A method of making a hydrogel having antimicrobial properties. The hydrogel includes a hydrogel-forming polymer and an anti-microbial agent. The method includes mixing a hydrogel-forming polymer, such as a hydrophilic polymer, with water and cross-linking the polymer and water using an energy source. The method does not require any chemical additive to affect the cross-linking. The anti-microbial agent may be mixed with the hydrogel-forming polymer and water prior to cross-linking. Alternatively, the anti-microbial agent may be applied to a substrate onto which the hydrogel is placed such that the anti-microbial agent or the properties of the agent, or both, migrate into the hydrogel. The substrate may be a liner onto which the hydrogel is placed, a scrim located on or in the hydrogel, or other appropriate device.
    Type: Application
    Filed: September 22, 2005
    Publication date: March 23, 2006
    Applicant: Noble Fiber Technologies, LLC
    Inventors: N. Chandra, William McNally, Joel Furey, Gregory Robb, Matthew Harriton